You are here

Healthcare Economics

 

Older adults with fewer risk factors for cardiovascular disease had lower all-cause and cardiovascular disease-related inpatient, outpatient and total healthcare expenditures, according to an analysis of Medicare fee-for-service beneficiaries.

Legislation that would allow advanced practice providers (APPs) to supervise cardiac rehabilitation under Medicare has been bottled up in Congress for several years. But for many in the healthcare field, the larger issue is how to optimize the skills and talents of APPs across the cardiovascular service line given the changes unfolding in the delivery of patient care.

Attendees at the first day of the American College of Cardiology (ACC) Cardiovascular Summit & Leadership Forum received “a big dose of MACRA,” said Howard T. Walpole, Jr. MD, MBA, course director and vice president of Clinical Effectiveness at Northeast Georgia Health System in Gainesville.

Readmissions for non-Medicare patients and in other settings are not as closely monitored, although a database analysis suggests that patients spend nearly a week in the hospital and cost nearly $10,000 per readmission.

Prescribing fixed-dose combination pills to patients with hypertension may help improve their adherence and persistence to their medications and encourage them to refill their prescription, according to a claims database analysis.

 

Recent Headlines

LVADs may not be cost-effective in Medicare beneficiaries

Medicare beneficiaries with heart failure who were implanted with left ventricular assist devices (LVADs) had a significantly increase in lifetime costs compared with those treated with medical management, according to a cost-effectiveness model.

Medtronic launches value-based healthcare program in Europe, Middle East, Africa

Medtronic announced a new professional development program in its Europe, Middle East and Africa regions to promote value-based healthcare initiatives.

Cardiovascular disease-related costs may double to $1.1 trillion by 2035

By 2035, an estimated 45 percent of the U.S. population could have cardiovascular disease, and the costs associated with the condition could nearly double from today to $1.1 trillion, according to a new report.

Healthcare utilization, expenditures are high after ICD shocks

Nearly 15 percent of patients had a shock event after receiving an implantable cardioverter-defibrillator (ICD), according to a retrospective cohort study.

Out-of-pocket spending for adults with heart disease, hypertension depends on insurance plan

Adults with heart disease, hypertension and other chronic disease who had a low-deductible or high-deductible plan had greater out-of-pocket spending and more frequent high medical cost burdens compared with those with no-deductible plans.

FDA fast tracks Generx cardiovascular angiogenic gene therapy

The U.S. Food and Drug Administration (FDA) granted a fast track designation for the Generx cardiovascular angiogenic gene therapy, which is being developed as a one-time treatment to improve exercise tolerance in patients with angina.

Study highlights costs associated with heart failure, acute MI readmissions

The mean length of stays in the hospital were 5.7 days for acute MI and 6.4 days for heart failure, while the mean costs per readmission were $9,424 and $9,051, respectively.

Merit Medical Systems acquires interventional cardiology products for $48 million

Merit Medical Systems announced on Feb. 6 that it had acquired interventional cardiology products from Argon Medical Devices and Catheter Connections.

Boston Scientific’s shares increase 5% after strong fourth quarter

During the fourth quarter of 2016, Boston Scientific’s sales increased 11 percent to $2.19 billion compared with the same time period in 2015, while its full-year sales for 2016 increased 12 percent to $8.84 billion compared with the previous year.

Medicare beneficiaries with fewer cardiovascular risk factors may have lower expenditures

Older adults with fewer risk factors for cardiovascular disease had lower all-cause and cardiovascular disease-related inpatient, outpatient and total healthcare expenditures, according to an analysis of Medicare fee-for-service beneficiaries.

Pages